Several major investors made sizable moves in Indian equities on December 22, with stakes changing hands in pharma, infrastructure, and sugar companies.
Ruby QC exits Akums Drugs
Ruby QC Investment Holdings sold its entire 4.62% holding – 7.278 million shares – in Akums Drugs and Pharmaceuticals. The shares were sold to ICICI Prudential Mutual Fund for about ₹311.5 crore, at ₹428 per share. After the sale, Akums stock rose 3.73% to ₹443.15, marking a third straight day of gains.
National Highways Infra Trust sees new unit buyer
Azim Premji‑backed Prazim Trading and Investment Company purchased 5.06 crore units (2.6% of the trust) for ₹754.24 crore, paying ₹149.06 per unit. The seller was Vidyaniti LLP, which previously held a 4.64% stake. The trust’s units were trading around ₹149, up 0.57%.
Changes in Modis Navnirman holdings
- RRS Family Trust bought 1.4 lakh shares for ₹4.83 crore (₹345 each).
- Aegis Investment Fund sold 2.37 lakh shares for ₹8.19 crore at the same price.
Activity in Shubhshree Biofuels Energy and TBI Corn
- Jinendra Kumar Jain purchased 26,700 shares of Shubhshree Biofuels Energy for ₹98.02 lakh (₹367.15 each) while Next Orbit Ventures Fund sold a similar amount.
- Jinendra also bought 1.2 lakh shares of TBI Corn for ₹98.34 lakh (₹81.95 each) from the same fund.
Heavy buying and selling in Davangere Sugar
The stock fell 19.5% to ₹3.55 after a prior rally. Multiple funds entered the trade:
- 3 Sigma Global Fund bought 1 crore shares for ₹4.1 crore (₹4.10 each).
- Craft Emerging Market Fund (via Elite Capital) took 2 crore shares for ₹8.2 crore.
- Beacon Stone Capital acquired 5 crore shares for ₹19.6 crore (₹3.92 each).
- On the sell side, Metasoni Alloys, Trade Corner, Ascent Wealth, and Arihant Capital Markets together sold over 10 crore shares, raising roughly ₹40 crore.
These bulk transactions highlight shifting confidence among institutional investors across sectors, from pharma to infrastructure and sugar.
Remember, this is just a snapshot of recent activity, not a prediction. Do your own research before making any investment decisions.